We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TNYA market cap is 40.38M. The company's latest EPS is USD -1.2688 and P/E is -0.36.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.45M | -33.76M | -30.82M | -26.71M | -24.65M |
| Net Income | -29.94M | -32.23M | -29.43M | -25.63M | -23.84M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.91M | -72.81M | -125.62M | -131.19M | -115.95M |
| Net Income | -38.4M | -72.72M | -123.67M | -124.08M | -111.13M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 170.52M | 184.9M | 163.19M | 140.58M | 119.94M |
| Total Liabilities | 31.09M | 26.72M | 29.19M | 27.98M | 27.09M |
| Total Equity | 139.42M | 158.18M | 134M | 112.6M | 92.85M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 148.16M | 314.19M | 278.95M | 170.52M | 119.94M |
| Total Liabilities | 8.72M | 35.66M | 35.57M | 31.09M | 27.09M |
| Total Equity | -81.32M | 278.53M | 243.38M | 139.42M | 92.85M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -102.07M | -28.66M | -52.28M | -72.11M | -90.5M |
| Investing | 48.72M | -4.49M | 17.13M | -12.97M | 1.13M |
| Financing | 4.05M | 46.77M | 47.34M | 47.37M | 47.75M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.45M | -60.81M | -104.42M | -102.07M | -90.5M |
| Investing | -7.01M | -238.56M | 83.65M | 48.72M | 1.13M |
| Financing | 147.27M | 208.97M | 77.77M | 4.05M | 47.75M |
| Market Cap | 40.38M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.31 |
| Price to Book Ratio | 0.43 |
| Dividend Yield | - |
| Shares Outstanding | 87.58M |
| Average Volume (1 week) | 1.5M |
| Average Volume (1 Month) | 2.58M |
| 52 Week Change | -89.84% |
| 52 Week High | 4.96 |
| 52 Week Low | 0.3941 |
| Spread (Intraday) | 0.02 (4.12%) |
| Company Name | Tenaya Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.tenayatherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
